MCB
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
MCB Accepts, published online ahead of print on 26 December 2007
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
MCB.01360-07v1
28/5/1713    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Xu, M.
Right arrow Articles by Sen, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xu, M.
Right arrow Articles by Sen, J. M.

 Previous Article  |  Next Article 

Mol. Cell. Biol. doi:10.1128/MCB.01360-07
Copyright (c) 2007, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

{beta}-Catenin Expression Results in p53-Independent DNA Damage and Oncogene-Induced-Senescence in Pre-lymphomagenic Thymocytes in-vivo

Mai Xu, Qing Yu, Ramesh Subrahmanyam, Michael J. Difilippantonio, Thomas Ried, and Jyoti Misra Sen*

Lymphocyte Development Unit, Laboratory of Immunology, Laboratory of Cellular and Molecular Biology, National Institute on Aging, Baltimore, MD 21224; Section of Cancer Genomics, Genetics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892

* To whom correspondence should be addressed. Email: Jyoti-Sen{at}NIH.GOV.


   Abstract

Expression of {beta}-Catenin, a potent oncogene, is causally linked to tumorigenesis. Therefore, it was surprising when transgenic expression of oncogenic {beta}-catenin in thymocytes resulted in thymic involution instead of lymphomagenesis. In this report we demonstrate that this is because expression of oncogenic {beta}-catenin induces DNA damage, growth arrest, oncogene-induced-senescence (OIS) and apoptosis of immature thymocytes. In p53-deficient mice, expression of oncogenic {beta}-catenin still results in DNA damage and OIS, but the thymocytes survive and eventually progress to thymic lymphoma. {beta}-Catenin-induced thymic lymphomas are distinct from lymphomas that arise in p53-/- mice. They are CD4-CD8- while p53-dependent lymphomas are largely CD4+CD8+, they develop at an earlier age and in the absence of c-Myc expression or Notch1 signaling. Thus, we report that oncogenic {beta}-catenin-induced, p53-independent growth arrest and OIS and p53-dependent apoptosis protect developing thymocytes from transformation by oncogenic {beta}-catenin.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2007 by the American Society for Microbiology. All rights reserved.